Stock comparison
IDEXX Laboratories
Perrigo
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
PRGO
Perrigo
Market cap
$1.55B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | PRGO | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 32F | IDXX |
| Benjamin Graham | 80A | 32F | IDXX |
| Philip Fisher | 75B | 20F | IDXX |
| Peter Lynch | 71B | 16F | IDXX |
| Joel Greenblatt | 83C | 19F | IDXX |
| Charlie Munger | 87A | 23F | IDXX |
| Terry Smith | 84A | 14F | IDXX |
Side-by-side metrics
| Metric | IDXX | PRGO |
|---|---|---|
| Market cap | $44.12B | $1.55B |
| P/E (TTM) | 39.0x | - |
| EV/EBIT | 31.6x | 14.5x |
| ROIC (TTM) | 40.66% | 3.37% |
| Gross margin | 62.05% | 34.17% |
| Net margin | 24.63% | -43.5% |
| Revenue CAGR 5y | 7.56% | 0.68% |
| EPS CAGR 5y | 10.79% | - |
| Debt / Equity | 0.7x | 1.5x |
| Dividend yield | 0.0% | 10.43% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Net margin24.63%vs -43.5%+157%
- Market cap$44.12Bvs $1.55B+96%
- ROIC (TTM)40.66%vs 3.37%+92%
- Revenue CAGR 5y7.56%vs 0.68%+91%
PRGO leads on
- P/E (TTM)-vs 39.0x+102%
- Dividend yield10.43%vs 0.0%+100%
- EV/EBIT14.5xvs 31.6x+54%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.